Abstract-(6R)-5,6,7,8-Tetrahydro-biopterin (H 4 B) is essential for the catalytic activity of all NO synthases. The hyperphenylalaninemic mouse mutant (hph-1) displays 90% deficiency of the GTP cyclohydrolase I, the rate-limiting enzyme in H 4 B synthesis. A relative shortage of H 4 B may shift the balance between endothelial NO synthase (eNOS)-catalyzed generation of NO and reactive oxygen species. Therefore, the hph-1 mouse represents a unique model to assess the effect of chronic H 4 B deficiency on endothelial function. Aortas from 8-week-old hph-1 and wild-type mice (C57BLϫCBA) were compared. H 4 B levels were determined by high-performance liquid chromatography and NO synthase activity by [ 3 H]citrulline assay in homogenized tissue. Superoxide production by the chemiluminescence method was measured. Isometric tension was continuously recorded. The intracellular levels of H 4 B as well as constitutive NO synthase activity were significantly lower in hph-1 compared with wild-type mice. Systolic blood pressure was increased in hph-1 mice. However, endothelium-dependent relaxations to acetylcholine were present in both groups and abolished by inhibition of NO synthase with N G -nitro-L-arginine methyl ester as well. Only in hph-1 mice were the relaxations inhibited by catalase and enhanced by superoxide dismutase. After incubation with exogenous H 4 B, the differences between the 2 groups disappeared. Our findings demonstrate that H 4 B deficiency leads to eNOS dysfunction with the formation of reactive oxygen species, which become mediators of endothelium-dependent relaxations. A decreased availability of H 4 B may favor an impaired activity of eNOS and thus contribute to the development of vascular diseases. In addition, H 4 B is required for the activity of all NO synthase (NOS) isoforms: neuronal NOS, endothelial NOS (eNOS), and inducible NOS. [2] [3] [4] [5] [6] These enzymes consist of a heme domain linked to an NADPH-cytochrome P-450 reductaselike diflavin domain. On Ca 2ϩ /calmodulin binding, the flavin adenine dinucleotide (FAD) transfers reducing equivalents from NADPH to flavin mononucleotide (FMN), which then reduces the heme iron. Reduction of the heme iron leads to oxygen activation followed by oxidation of L-arginine to NO and L-citrulline. 7 The precise role of H 4 B in NO synthesis is not completely understood; however, H 4 B has been postulated to determine whether the electron flow within the enzyme can be directed to L-arginine. 8 NO generated by eNOS contributes to the regulation of systemic blood pressure, and it has been shown to be antiatherogenic and critical for angiogenesis. 9,10 Although it is well established that inherent errors in the metabolism of H 4 B lead to cofactor deficiency, hyperphenylalaninemia, and neurological impairment, 11 an important role for H 4 B in the cardiovascular system has been recognized only recently. 12 A close link between cellular H 4 B availability and NO synthesis has been demonstrated in endothelial cells. Indeed, in porcine and human vascular endothelial cells, inhibition of GTP cyclohydrolase I, the rate-limiting enzyme in H 4 B synthesis, reduces the production of NO in response to the calcium ionophore A23187 or bradykinin. 5, 13, 14 These studies provided evidence that in cultured endothelial cells, an optimal concentration of H 4 B is essential for the agonist-induced calcium-dependent production of NO. Furthermore, several biochemical studies have demonstrated that activation of purified constitutive NOS (cNOS) at suboptimal concentrations of the cofactor results in uncoupling of oxygen reduction and arginine oxidation, thereby generating superoxide anion (O 2 Ϫ ) and hydrogen peroxide (H 2 O 2 ). 15-17 These findings were also confirmed in intact blood vessels depleted of H 4 B, suggesting that eNOS may become a source of oxygen-
(6R) -5,6 ,7,8-Tetrahydro-biopterin (H 4 B) is a cofactor of aromatic amino acid hydroxylases, which are regarded as key enzymes in the biosynthesis of several neurotransmitters, including catecholamines and serotonin. 1 In addition, H 4 B is required for the activity of all NO synthase (NOS) isoforms: neuronal NOS, endothelial NOS (eNOS), and inducible NOS. [2] [3] [4] [5] [6] These enzymes consist of a heme domain linked to an NADPH-cytochrome P-450 reductaselike diflavin domain. On Ca 2ϩ /calmodulin binding, the flavin adenine dinucleotide (FAD) transfers reducing equivalents from NADPH to flavin mononucleotide (FMN), which then reduces the heme iron. Reduction of the heme iron leads to oxygen activation followed by oxidation of L-arginine to NO and L-citrulline. 7 The precise role of H 4 B in NO synthesis is not completely understood; however, H 4 B has been postulated to determine whether the electron flow within the enzyme can be directed to L-arginine. 8 NO generated by eNOS contributes to the regulation of systemic blood pressure, and it has been shown to be antiatherogenic and critical for angiogenesis. 9, 10 Although it is well established that inherent errors in the metabolism of H 4 B lead to cofactor deficiency, hyperphenylalaninemia, and neurological impairment, 11 an important role for H 4 B in the cardiovascular system has been recognized only recently. 12 A close link between cellular H 4 B availability and NO synthesis has been demonstrated in endothelial cells. Indeed, in porcine and human vascular endothelial cells, inhibition of GTP cyclohydrolase I, the rate-limiting enzyme in H 4 B synthesis, reduces the production of NO in response to the calcium ionophore A23187 or bradykinin. 5, 13, 14 These studies provided evidence that in cultured endothelial cells, an optimal concentration of H 4 B is essential for the agonist-induced calcium-dependent production of NO. Furthermore, several biochemical studies have demonstrated that activation of purified constitutive NOS (cNOS) at suboptimal concentrations of the cofactor results in uncoupling of oxygen reduction and arginine oxidation, thereby generating superoxide anion (O 2 Ϫ ) and hydrogen peroxide (H 2 O 2 ). [15] [16] [17] These findings were also confirmed in intact blood vessels depleted of H 4 B, suggesting that eNOS may become a source of oxygen-derived free radicals. 18, 19 High-resolution crystal structure of the eNOS heme domain alone and also in complex with H 4 B has shed light on the role of reduced pterin in sustaining NOS catalysis. 20 Under conditions of reduced H 4 B availability, there is strong evidence for superoxide generation by eNOS. 17 This is of physiological interest because H 4 B depletion is associated with vascular pathology. 21 The hypothesis that a relative shortage of H 4 B may cause a shift in the balance between NOS-catalyzed generation of protective NO and deleterious reactive oxygen species deserves further investigation. If correct, this hypothesis may represent an important mechanism underlying endothelial dysfunction and oxidative vascular injury described in a number of vascular diseases, including atherosclerosis. 10, 22 Recently, a mouse model of H 4 B deficiency has been developed by use of the sperm mutagen N-ethyl-NЈ-nitrosourea. 23 The hyperphenylalaninemic mouse mutant (hph-1) displays 90% deficiency in GTP cyclohydrolase I activity, the enzyme catalyzing the first committed step in H 4 B synthesis. 24 This enzyme deficiency results in reduced tissue H 4 B concentrations compared with concentrations in the wild-type mice of the same strain (C57BLϫCBA). 25, 26 Therefore, the hph-1 mouse represents a unique model to assess the effect of chronic H 4 B deficiency on vascular endothelial function in the intact organism.
Methods

Animals
The experiments were performed on aortas of male hph-1 and wild-type (C57BLϫCBA) mice of the same strain (8 weeks old). All procedures were in accordance with institutional guidelines. Body weights of the mice were recorded. Systolic blood pressure and heart rate were measured in conscious mice by a tail-cuff method with the use of a pulse transducer (model LE 5000, Letica). Blood samples were taken in chilled EDTA tubes for the determination of plasma total cholesterol levels. Animals were killed by cervical dislocation. 
Measurement of Intracellular Tetrahydrobiopterin
H 4 B levels were measured in aortas from both groups of mice. Aortas were homogenized (5% [wt/vol]) in 0.1 mol/L perchloric acid containing 6.5 mmol/L dithioerythritol, 2.5 mmol/L diethylenetriaminepentaacetic acid, and 375 U/mL heparin. Samples were centrifuged at 15 000g for 5 minutes, and 100 L of supernatant was injected onto a high-performance liquid chromatographic system. Analysis of H 4 B was determined as described previously. 27 
Determination of cNOS Activity
Determination of cNOS activity was carried out as described. 28 Briefly, tissue extracts were freed from low molecular weight compounds with NAP-5 columns (Pharmacia). 
Measurement of Superoxide by Lucigenin-Mediated Chemiluminescence
Superoxide (O 2 Ϫ ) production was determined by a chemiluminescence method. 29 Freshly harvested aortas were opened lengthwise, divided into multiple segments, and equilibrated in Krebs-HEPES buffer (composition in mmol/L: NaCl 99, KCl 4.7, MgSO 4 1.2, KH 2 PO 4 1, CaCl 2 1.9, NaHCO 3 25, glucose 11.1, and sodium HEPES 20) gassed with 95% O 2 /5% CO 2 for 30 minutes at 37°C in the presence of indomethacin (10 Ϫ5 mol/L). Lucigenin-enhanced chemiluminescence was measured in 2 mL Krebs-HEPES buffer containing lucigenin (5 mol/L) by use of a Berthold FB12 single tube luminometer, modified to maintain a sample temperature of 37°C. Chemiluminescence was measured continuously for 10 minutes after allowing dark adaptation and was expressed as relative light units (RLU) per minute per milligram vessel dry weight.
Organ Chamber Experiments
Aortas were cut into rings (3 to 4 mm long). In certain rings, the endothelium was mechanically removed. All experiments were performed in the presence of indomethacin (10 Ϫ5 mol/L) to prevent the formation of prostaglandins. Each ring was connected to an isometric force transducer (SCAIME), suspended in an organ chamber filled with 5 mL control solution (37°C, pH 7.4), and bubbled with 95% O 2 /5% CO 2 . Isometric tension was recorded continuously. After a 30-minute equilibration period, rings were gradually stretched to the optimal point of their length-tension curve (1.5Ϯ0.2 g) as determined by the contraction to norepinephrine (10 Ϫ6 mol/L). The functional integrity of the endothelium was tested by the presence of relaxations to acetylcholine (10 Ϫ6 mol/L). Concentrationresponse curves were obtained in a cumulative fashion. Several rings cut from the same artery were studied in parallel; only 1 concentration-response curve was made per preparation. In quiescent preparations, indomethacin, N G -nitro-L-arginine methyl ester (L-NAME), catalase, and superoxide dismutase (SOD) did not affect resting tension. Responses to acetylcholine were obtained during submaximal contraction to norepinephrine (10 Ϫ6 mol/L). Incubation time was 60 minutes for H 4 B, 30 minutes for indomethacin, 15 minutes for L-NAME, and 5 minutes for catalase and SOD. Relaxations were expressed as a percentage of maximal relaxations induced by papaverine (3ϫ10 Ϫ4 mol/L).
Drugs
Acetylcholine chloride, catalase (C-100 from bovine liver, 58 000 U/mg protein), indomethacin, L-NAME, norepinephrine, papaverine hydrochloride, sodium nitroprusside, SOD (from bovine erythrocytes, 4400 U/mg protein), and chemical components of the control solution were obtained from Sigma Chemical Company. H 4 B dihydrochloride was obtained from Schircks Laboratories and prepared just before administration with the use of oxygen-free distilled water. Stock solutions of the drugs were freshly prepared every day. A stock solution of 10 Ϫ5 mol/L indomethacin was prepared in equimolar concentrations of Na 2 CO 3 . All concentrations are expressed as final molar concentration in the bath solutions.
Statistical Analysis
All experiments were performed in parallel on preparations from hph-1 and wild-type mice. In all experiments, n equals the number of mice per experiment. Results are expressed as meanϮSEM. Statistical evaluation of the data was performed by using Student t test for simple comparison between 2 values when appropriate. For multiple comparisons, results were analyzed by ANOVA. A value of PϽ0.05 was considered statistically significant.
Results
Characteristics of Animals
The body weight, systolic blood pressure, heart rate, and plasma total cholesterol levels of 8-week-old male hph-1 and
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wild-type (C57BLϫCBA) mice of the same strain are shown in Table 1 . In hph-1 mice, the systolic blood pressure was higher than that in the wild-type control mice.
Levels of H 4 B and Measurements of cNOS Activity
The intracellular levels of H 4 B in the aortas obtained from both groups were significantly lower in the mutant compared with the wild-type control mice ( Figure 1A ). Accordingly, cNOS activity assayed without the addition of exogenous H 4 B was significantly lower in hph-1 aortas (0.8Ϯ0.03 and
, respectively; nϭ3; PϽ0.05; Figure 1B ). By contrast, cNOS activity assayed with the addition of exogenous H 4 B (10 Ϫ5 mol/L) was comparable between the 2 groups (10Ϯ0.7 and 7.4Ϯ0.9 pmol ⅐ mg Ϫ1 ⅐ minute Ϫ1 , respectively; Figure 1B ).
Superoxide Anion Generation
O 2
Ϫ production was measured in the aortas of wild-type and hph-1 mice under basal conditions and after inhibition of NOS (Figure 2 
Vascular Contractions to Norepinephrine
The contractions to norepinephrine (10 Ϫ6 mol/L) did not differ between the 2 groups (Table 2) . Furthermore, the treatments with L-NAME, catalase, superoxide dismutase, or exogenous H 4 B did not affect the response to norepinephrine (Table 2) .
Endothelium-Dependent Relaxations to Acetylcholine
During contractions to norepinephrine (10 Ϫ6 mol/L), acetylcholine (10 Ϫ9 to 10 Ϫ6 mol/L) caused endothelium-dependent relaxations in mutant and wild-type mice (Figure 3 ). Inhibition of NOS with L-NAME (3ϫ10 Ϫ4 mol/L) abolished the relaxations to acetylcholine in both groups (Figure 3 , PϽ0.05 versus control). However, only in mutant mice were the relaxations significantly inhibited by catalase (1200 U/mL, 
Endothelium-Indepedent Relaxations to Sodium Nitroprusside
During contraction induced with norepinephrine, the NO donor sodium nitroprusside (10 Ϫ10 to 10 Ϫ5 mol/L) caused similar concentration-dependent relaxations in both groups. Catalase did not affect the relaxations to sodium nitroprusside ( Figure 6 ).
Discussion
The present study demonstrates that in an animal model of H 4 B deficiency, endothelium-dependent relaxations are in part mediated by eNOS-catalyzed production of oxygenderived free radicals. This conclusion is supported by several lines of evidence. In spite of lower intracellular levels of H 4 B and concomitant loss of cNOS activity in hph-1 compared with wild-type mice, the endothelium-dependent relaxations to acetylcholine were present in the aortas of both groups. Inhibition of NOS with L-NAME abolished these relaxations in H 4 B-deficient mice as well as in control mice. Only in mutant mice were the endothelium-dependent relaxations inhibited by catalase, a selective scavenger of H 2 O 2 . In the presence of exogenous H 4 B, the inhibitory effect of catalase disappeared. Furthermore, relaxations to acetylcholine in hph-1 mice were enhanced by SOD, an enzyme that rapidly converts O 2 Ϫ into H 2 O 2 and oxygen. Accordingly, O 2 Ϫ production was significantly decreased in hph-1 mice after NOS inhibition. These findings suggest that under conditions of in vivo H 4 B deficiency, H 2 O 2 , a product of O 2 Ϫ dismutation formed via eNOS, becomes a mediator of endotheliumdependent relaxations.
It is well established that all NOS isoforms catalyze a 5-electron oxidation of L-arginine to L-citrulline, producing stoichiometric amounts of NO in the process. Therefore, our observation of a reduced cNOS activity (measured as production of L-citrulline) that is associated with apparently normal relaxations to acetylcholine in hph-1 mice is consistent with the concept of a dysfunctional NOS. A relative shortage of H 4 B may indeed lead to an uncoupling between L-arginine oxidation and production of L-citrulline and NO, resulting in a shift between NOS-dependent generation of NO and reactive oxygen species with vasorelaxing properties. Previous studies 30, 31 have provided evidence that H 2 O 2 is a potent vasodilator through direct activation of soluble guanylate cyclase in smooth muscle cells and an increase in cGMP. The present findings are in agreement with previously reported results in which a dysfunction of eNOS occurred in isolated arteries and cultured endothelial cells depleted of H 4 B. 5, 13, 18, 19 In canine coronary arteries incubated with the GTP cyclohydrolase I inhibitor 2,4-diamino-6-hydroxypyrimidine, endothelium-dependent relaxations to calcium ionophore and its stimulating effect on cGMP production were reduced by the H 2 O 2 scavenger catalase. 18 The present study clearly strengthens the concept of an interrelationship between the availability of H 4 B and eNOS activity. NOS-catalyzed conversion of L-arginine to L-citrulline and NO exhibits unique complexity and requirements for cofactors. 6 In the presence of optimal concentrations of H 4 B, L-arginine undergoes oxidative cleavage to yield NO and L-citrulline. The required reducing equivalents are derived from NADPH and are shuttled through the reduced flavins, FAD and FMN to the heme group. [32] [33] [34] This built-in electron transport system is used to oxidize L-arginine to NO and L-citrulline. H 4 B fully couples L-arginine oxidation to NADPH consumption. Indeed, in the presence of suboptimal levels of H 4 B, there is strong evidence for O 2 Ϫ and H 2 O 2 generation by purified eNOS. 17, 20 Furthermore, it was recently found that increased generation of O 2 Ϫ in cultured endothelial cells exposed to LDLs can be inhibited by L-NAME. 35 These data support the hypothesis that NOS itself can be an important source for the endothelial production of reactive oxygen species. In our present study, confirmation that NOS contributes to O 2 Ϫ generation in hph-1 mice comes from experiments showing a significant inhibition of O 2 Ϫ release after incubation with L-NMMA. By contrast, preincubation of control mouse aortas with the L-arginine analogue resulted in an increase in vascular O 2 Ϫ release. It is likely that in wild-type aortas, the activity of common sources of O 2 Ϫ , such as NADPH oxidase, cyclooxygenase, and xanthine-oxidase associated with the inhibition of NOS-catalyzed generation of NO, results in the loss of the NO-scavenging effect and, hence, increased O 2 Ϫ concentration. The opposite effect exerted by L-NMMA in mutant mice suggests that NO production is already impaired in these animals and that NOS catalytic activity is shifted toward O 2 Ϫ generation. Because all the experiments in the present study were performed in the presence of indomethacin, it is possible to rule out the possibility that oxygenderived free radical production was initiated by the activation of arachidonic acid metabolism via the cyclooxygenase pathway. Also, we ruled out the possibility that reactive oxygen species are produced by smooth muscle cells in hph-1 aortas. Indeed, catalase did not affect relaxations to the NO donor sodium nitroprusside in preparations without endothelium.
To validate the decreased intracellular availability of H 4 B as the mechanism leading to such eNOS-catalyzed production of oxygen-derived free radicals, we measured the levels of H 4 B and the activity of cNOS in the vessel wall. Under basal conditions, these measurements revealed a significantly lower tissue concentration of the cofactor as well as loss of NOS activity (measured as picomoles of L-citrulline produced per milligram of aortic tissue per minute) in aortas from mutant mice compared with those from wild-type control mice. However, with the addition of exogenous H 4 B, the activity of cNOS was comparable between the 2 groups. The same findings were obtained for brain concentrations of H 4 B and whole-brain NOS activity in the hph-1 mice. 26 In spite of such reduced enzymatic activity, relaxations to acetylcholine were similar to those in the control group and were abolished by the inhibition of NOS with L-NAME as well. However, the selective effects of catalase and SOD on the acetylcholineinduced responses only in H 4 B-deficient mice clearly indicate that the endothelium-dependent relaxations are in part mediated by eNOS-catalyzed generation of reactive oxygen species. Accordingly, incubation of hph-1 aortas with supplementary H 4 B abolished the inhibitory effect of catalase on endothelium-dependent relaxations to acetylcholine. This shows that an optimal concentration of H 4 B is critical for calcium-dependent production of NO and L-citrulline.
An important aspect of the present study is that our findings for the first time were obtained in an in vivo model of chronic deficiency of H 4 B and not through a pharmacologically induced depletion of the cofactor.
Although the endothelium-dependent relaxations to acetylcholine are apparently unchanged in H 4 B-deficient mice compared with wild-type control mice, an increased generation of O 2 Ϫ and its dismutase product H 2 O 2 in the long-term may contribute to endothelial dysfunction. Our results do not allow any conclusion regarding the relative amount of reactive oxygen species versus NO produced, but such NOScatalyzed formation of O 2 Ϫ and its subsequent dismutation into H 2 O 2 and OH radical or its transformation into peroxynitrite cleavage products may represent an important mechanism underlying oxidative injury described in a number of vascular diseases. 36 Indeed, recent clinical studies have demonstrated that administration of H 4 B improves endothelial dysfunction in conditions characterized by reduced availability of NO and increased production of reactive oxygen species, such as hypercholesterolemia, 37 coronary artery disease, 38 and smoking. 39 -41 Several other reports suggest that H 4 B may play a role in endothelial dysfunction during hypertension, 21 ischemia/reperfusion, 42 and experimental diabetes. 43 In this regard, hph-1 mice had a higher systolic blood pressure compared with that in control mice. It is of interest to note that basal NOS activity was reduced in mutant mice. Blockade of basal NO production by specific inhibitors of NOS induces persistent hypertension in animals 44, 45 and increases blood pressure in humans. 46 Furthermore, basal NOS activity is reduced in hypertensive patients, as judged by the urinary [ 15 N]nitrate excretion. 47 Thus, our findings suggest the importance of eNOS dysfunction in the setting of reduced H 4 B levels for blood pressure regulation. In line with this interpretation, we have previously found that an impaired synthesis of H 4 B in prehypertensive rats may contribute to the development of hypertension or its complications. 21 However, a variety of other mechanisms, such as neurological disorders, microcirculatory rarefaction, and renal aspects, might account for hypertension in hph-1 mice. There is substantial evidence to rule out an increased activity of the autonomic nervous system. Indeed, this in vivo model of H 4 B deficiency is characterized by an impaired biosynthesis of catecholamines and serotonin. 48 Taken together, all these data suggest that conditions associated with impaired NO activity and accelerated atherosclerosis may be characterized by a reduced availability of H 4 B. The background for such a reduced availability is not clear. 49 Decreases in cellular H 4 B concentration and in H 4 B binding affinity may alter eNOS activity in favor of oxygenderived free radical generation. 21 The identification of signal transduction pathways involved in the control of gene expression and activity of GTP cyclohydrolase I 50 as well as characterization of the precise role of H 4 B in regulation of NOS catalytic activity 51, 20 will help us to understand how an impairment of H 4 B availability may take place in vascular diseases and provide new targets for pharmacotherapy.
